CD8A and neoplasm: It has been illustrated that tumors lacking immune infiltration are associated with the poorest prognosis in patients with ER-negative breast cancer, whereas an increase in the proportion of CD8+ T cells in tumor tissue is associated with improved outcomes in cancers of the same subtype (17).